Journal of Neuro-Oncology

Papers
(The H4-Index of Journal of Neuro-Oncology is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Immune suppression in gliomas159
The prognostic significance of CDKN2A homozygous deletion in IDH-mutant lower-grade glioma and glioblastoma: a systematic review of the contemporary literature69
Response to trametinib treatment in progressive pediatric low-grade glioma patients68
Convection-enhanced drug delivery for glioblastoma: a review53
A systematic review and meta-analysis of supratotal versus gross total resection for glioblastoma50
Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer48
Neuroimmunological adverse events associated with immune checkpoint inhibitor: a retrospective, pharmacovigilance study using FAERS database47
Standardized intraoperative 5-ALA photodynamic therapy for newly diagnosed glioblastoma patients: a preliminary analysis of the INDYGO clinical trial47
Boron neutron capture therapy for malignant brain tumors47
Intraoperative MRI for Brain Tumors47
Temozolomide treatment outcomes and immunotherapy efficacy in brain tumor44
Laser interstitial thermotherapy (LITT) for the treatment of tumors of the brain and spine: a brief review44
Trametinib for the treatment of recurrent/progressive pediatric low-grade glioma43
Immune checkpoint inhibition for pediatric patients with recurrent/refractory CNS tumors: a single institution experience41
Survival benefit of lobectomy for glioblastoma: moving towards radical supramaximal resection39
Combination immunotherapy strategies for glioblastoma38
High-grade astrocytoma with piloid features (HGAP): the Charité experience with a new central nervous system tumor entity38
Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice37
Neurotoxicities associated with immune checkpoint inhibitor therapy36
Magnetic Hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: a systematic review36
Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review34
Laser interstitial thermal therapy (LITT) vs. bevacizumab for radiation necrosis in previously irradiated brain metastases32
Diffuse midline glioma: review of epigenetics30
Minimally invasive resection of intracranial lesions using tubular retractors: a large, multi-surgeon, multi-institutional series30
Atypical teratoid rhabdoid tumor: molecular insights and translation to novel therapeutics30
Label-free brain tumor imaging using Raman-based methods29
Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid29
Focused ultrasound for the treatment of glioblastoma29
Serum microRNA is a biomarker for post-operative monitoring in glioma28
0.16764378547668